SCHEMBL5666281

SCHEMBL5666281

O=C[C@H](OC(=O)c1cc(OC(=O)c2cc(O)c(O)c(O)c2)c(OC(=O)c2cc(O)c(O)c(O)c2)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)[C@@H](OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)[C@H](OC(=O)c1cc(O)c(O)c(O)c1)[C@@H](COC(=O)c1cc(O)c(O)c(O)c1)OC(=O)c1cc(O)c(O)c(O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 8/20 0.46
POLB P06746 1/20 0.41
POLA1 P09884 1/20 0.41
ANTXR2 P58335 1/20 0.41
PTPN1 P18031 3/20 0.40
PTPN2 P17706 1/20 0.40
PTPN11 Q06124 1/20 0.40
TMPRSS2 O15393 1/20 0.39
USP2 O75604 1/20 0.39
PDE5A O76074 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
HMGCR P04035 1/20 0.39
CYP1A2 P05177 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
HSPD1 P10809 1/20 0.39
CYP2C9 P11712 1/20 0.39
CA6 P23280 1/20 0.39
TBXAS1 P24557 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5665190 0.99 SERPINE1 (0.47) SERPINE1POLBPOLA1ANTXR2PTPN1
SCHEMBL5665855 0.97 SERPINE1 (0.45) SERPINE1POLBPOLA1ANTXR2PTPN1
SCHEMBL5908258 0.96 SERPINE1 (0.46) SERPINE1POLBPOLA1ANTXR2PTPN1
SCHEMBL29935518 0.96 SERPINE1 (0.50) SERPINE1POLBPOLA1ANTXR2PTPN1
SCHEMBL391922 0.89 SERPINE1 (0.57) SERPINE1PTPN1PTPN2PTPN11TYR
SCHEMBL28031026 0.89 SERPINE1 (0.57) SERPINE1PTPN1PTPN2PTPN11TYR
Water SCHEMBL23067557 0.88 SERPINE1 (0.56) SERPINE1PTPN1PTPN2PTPN11TYR
SCHEMBL9646034 0.82 SERPINE1 (0.46) SERPINE1POLBPTPN1PTPN2PTPN11
SCHEMBL20530411 0.78 SERPINE1 (0.57) SERPINE1PTPN1PTPN2PTPN11L3MBTL1
SCHEMBL28064168 0.78 SERPINE1 (0.57) SERPINE1PTPN1PTPN2PTPN11L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1545554-A4 METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS UNIV OHIO (US) 2006-06-14 EP claimed
US-20060058243-A1 Methods and compositions for treating diabetes mellitis OHIO UNIVERSITY 2006-03-16 US claimed
EP-1545554-A1 METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS Ohio University (US) 2005-06-29 EP claimed
WO-2004009094-A1 METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS OHIO UNIVERSITY (US) 2004-01-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058243-A1 Methods and compositions for treating diabetes mellitis IAPP, GCG, MTPN SERPINE1 196/4885POLB 4432/4885POLA1 4532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.